Emerging scientific evidence has suggested that the long non-coding (lnc)RNA differentiation antagonizing non-protein coding RNA (
DANCR
) serves a significant role in human tumorigenesis and cancer progression; however, the precise mechanism of its function in breast cancer remains to be fully understood. Therefore, the objective of the present study was to manipulate
DANCR
expression in MCF7 and MDA-MB-231 cells using lentiviral vectors to knock down or overexpress
DANCR
. This manipulation, alongside the analysis of bioinformatics data, was performed to investigate the potential mechanism underlying the role of
DANCR
in cancer. The mRNA and/or protein expression levels of
DANCR, miR-34c-5p
and E2F transcription factor 1 (
E2F1
) were assessed using reverse transcription-quantitative PCR and western blotting, respectively. The interactions between these molecules were validated using chromatin immunoprecipitation and dual-luciferase reporter assays. Additionally, fluorescence
in situ
hybridization was used to confirm the subcellular localization of
DANCR
. Cell proliferation, migration and invasion were determined using 5-ethynyl-2′-deoxyuridine, wound healing and Transwell assays, respectively. The results of the present study demonstrated that
DANCR
had a regulatory role as a competing endogenous RNA and upregulated the expression of
E2F1
by sequestering
miR-34c-5p
in breast cancer cells. Furthermore,
E2F1
promoted
DANCR
transcription by binding to its promoter in breast cancer cells. Notably, the
DANCR
/
miR-34c-5p
/
E2F1
feedback loop enhanced cell proliferation, migration and invasion in breast cancer cells. Thus, these findings suggested that targeting
DANCR
may potentially provide a promising future therapeutic strategy for breast cancer treatment.